Clinical Trials Directory

Trials / Completed

CompletedNCT04333212

HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix

Human Papillomavirus Detection and Genotyping by DR. HPV Genotyping IVD Kit in Exfoliated Cells of the Uterine Cervix

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,103 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
Female
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

High-risk type human papillomavirus (HPV) is the known etiological agent of cervical cancer. HPV testing and risk stratification by genotyping has been recognized as an effective cervical screening program. A chip for HPV DNA typing based on type-specific polymerase chain reaction (PCR), DR. HPV Genotyping IVD Kit (HPV-27) was developed for genotyping of 27 common HPV types including all high-risk types. We studied its agreement, sensitivity, and specificity compared to DNA sequencing as the gold standard.

Detailed description

High-risk type human papillomavirus (HPV) is the known etiological agent of cervical cancer. HPV testing and risk stratification by genotyping has been recognized as an effective cervical screening program. HPV detection is also applied for triage of atypical squamous cells of undetermined significance and follow-up after treatment for cervical neoplasms. A chip for HPV DNA typing based on type-specific polymerase chain reaction (PCR), DR. HPV Genotyping IVD Kit (HPV-27) was developed for genotyping of 27 common HPV types including all high-risk types. We studied its agreement, sensitivity, and specificity compared to DNA sequencing as the gold standard. One-thousand one-hundred and three (1103) subjects were enrolled between December 2012 and December 2013 from Linkou Chang Gung Memorial Hospital, Mackay Memorial Hospital, Changhua Christian Hospital, and Cathay General Hospital.

Conditions

Interventions

TypeNameDescription
DEVICEDR. Chip HPV genotyping IVD kitHPV typing by gene chip

Timeline

Start date
2012-12-12
Primary completion
2013-12-30
Completion
2014-07-08
First posted
2020-04-03
Last updated
2020-04-03

Locations

4 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04333212. Inclusion in this directory is not an endorsement.